Exploring adjunctive therapies for cerebral malaria
Frontiers in Cellular and Infection Microbiology · 12.02.2024 · 14
DOI: 10.3389/fcimb.2024.1347486 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 12.02.2024. Verfasst von Johanna Bensalel und 1 weiteren Autor:innen. Beteiligte Einrichtung: Ph.D. Program in Biology, The Graduate Center, The City University of New York, New York, NY, United States. Hauptthemen laut MEDLINE: Malaria, Cerebral. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS.
Abstract (Originalsprache)
Cerebral malaria (CM) is one of the most severe complications of malaria infection characterized by coma and neurological effects. Despite standardized treatment of malaria infection with artemisinin-based combination therapies (ACT), the mortality rate is still high, and it primarily affects pediatric patients. ACT reduces parasitemia but fails to adequately target the pathogenic mechanisms underlying CM, including blood-brain-barrier (BBB) disruption, endothelial activation/dysfunction, and hyperinflammation. The need for adjunctive therapies to specifically treat this form of severe malaria is critical as hundreds of thousands of people continue to die each year from this disease. Here we present a summary of some potential promising therapeutic targets and treatments for CM, as well as some that have been tested and deemed ineffective or, in some cases, even deleterious. Further exploration into these therapeutic agents is warranted to assess the effectiveness of these potential treatments for CM patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Ph.D. Program in Biology, The Graduate Center, The City University of New York, New York, NY, United States.
- Department of Biological Sciences, Lehman College, City University of New York, New York, NY, United States.
- Ph.D. Program in Biochemistry, The Graduate Center, The City University of New York, New York, NY, United States.
Förderung
- NIGMS NIH HHS
Zitieren
APA
Bensalel, J., & Gallego-Delgado, J. (2024). Exploring adjunctive therapies for cerebral malaria. Frontiers in Cellular and Infection Microbiology, 14. https://doi.org/10.3389/fcimb.2024.1347486
Vancouver
Bensalel J, Gallego-Delgado J. Exploring adjunctive therapies for cerebral malaria. Frontiers in Cellular and Infection Microbiology. 2024;14. doi:10.3389/fcimb.2024.1347486
BibTeX
@article{Bensalel2024,
author = {Bensalel, Johanna and Gallego-Delgado, Julio},
title = {Exploring adjunctive therapies for cerebral malaria},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2024},
volume = {14},
doi = {10.3389/fcimb.2024.1347486}
}
EUVIMED